Will coronavirus disease (COVID-19) have an impact on antimicrobial resistance?

Monnet, Dominique L; Harbarth, Stephan

Monnet, Dominique L; Harbarth, Stephan.

Monnet DL; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Harbarth S; Infection Control Program and Division of Infectious Diseases, University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland.

Euro Surveill ; 25(45)2020 Nov.

Article in English | MEDLINE | ID: covidwho-922780

Subject(s)

Anti-Bacterial Agents/pharmacology; Antimicrobial Stewardship/organization & administration; Coronavirus; Drug Resistance, Bacterial; Betacoronavirus; COVID-19; Coronavirus Infections/epidemiology; Disinfectants/administration & dosage; Humans; Pandemics/prevention & control; Pneumonia, Viral/epidemiology; SARS-CoV-2

Keywords

COVID-19; antibiotic use; antimicrobial resistance; automated surveillance; bacterial infections; hygiene; infection control; respiratory viruses; surveillance; viral infections

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Coronavirus / Drug Resistance, Bacterial / Antimicrobial Stewardship / Anti-Bacterial Agents Type of study: Experimental Studies / Observational study Limits: Humans Language: English Journal subject: Communicable Diseases Year: 2020 Document Type: Article Affiliation country: 1560-7917.Es.2020.25.45.2001886

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google